Pfizer oral p38 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pfizer oral p38 inhibitor, covering 2021-08-20 to 2021-08-20. Get the full timeline:
Most recent: Clinical Trial Update: An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis [Phase 2]